Eric Therrien

Eric Therrien is a renowned Director of Computational Chemistry at Schrödinger, where leadership spans collaborative and internal discovery programs in oncology, immunology, and neurology since September 2016. Prior roles include Senior Principal Scientist at Schrödinger, contributing to significant discoveries such as KAI-11101 and various inhibitors targeting cancer-related pathways. Also, Eric co-founded Molecular Forecaster, a McGill University spin-off, and served as a Research Scientist at IntelliSyn R&D, focusing on structure-based synthesis of enzyme inhibitors. Experience includes senior roles in developing kinase inhibitors at Laboratoires ChemRF and research positions at McGill University and MethylGene Inc., with a PhD in Organic Chemistry from Université de Montréal.